A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts
- 18 August 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (12), 4253-4263
- https://doi.org/10.1096/fj.11-186585
Abstract
The primary graft-related complication during the first clinical trial evaluating the use of tissue-engineered vascular grafts (TEVGs) was stenosis. We investigated the role of macrophages in the formation of TEVG stenosis in a murine model. We analyzed the natural history of TEVG macrophage infiltration at critical time points and evaluated the role of cell seeding on neovessel formation. To assess the function of infiltrating macrophages, we implanted TEVGs into mice that had been macrophage depleted using clodronate liposomes. To confirm this, we used a CD11b-diphtheria toxin-receptor (DTR) transgenic mouse model. Monocytes infiltrated the scaffold within the first few days and initially transformed into M1 macrophages. As the scaffold degraded, the macrophage infiltrate disappeared. Cell seeding decreased the incidence of stenosis (32% seeded, 64% unseeded, P=0.024) and the degree of macrophage infiltration at 2 wk. Unseeded TEVGs demonstrated conversion from M1 to M2 phenotype, whereas seeded grafts did not. Clodronate and DTR inhibited macrophage infiltration and decreased stenosis but blocked formation of vascular neotissue, evidenced by the absence of endothelial and smooth muscle cells and collagen. These findings suggest that macrophage infiltration is critical for neovessel formation and provides a strategy for predicting, detecting, and inhibiting stenosis in TEVGs.Keywords
Funding Information
- National Institutes of Health (K08HL083980)
- National Institutes of Health (R01HL098228)
- National Institutes of Health (UL1RR024139)
- National Institutes of Health (P30DK072442)
- National Institutes of Health (P01HL070295)
This publication has 41 references indexed in Scilit:
- Tissue‐engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vesselThe FASEB Journal, 2011
- Tissue-engineered vascular grafts: does cell seeding matter?Journal of Pediatric Surgery, 2010
- Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodelingProceedings of the National Academy of Sciences of the United States of America, 2010
- Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular componentBiomaterials, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- Tissue-engineered Vascular Grafts Demonstrate Evidence of Growth and Development When Implanted in a Juvenile Animal ModelAnnals of Surgery, 2008
- Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse modelBiomaterials, 2008
- Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established PlaquesCirculation Research, 2007
- Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-β1 in healing rat vein graftsJournal of Vascular Surgery, 2004